Company: DRTSW
Filing Date: 2025-03-12
Form Type: 20-F
Source: 0001213900-25-023187
Chunk: 320

Company: Alpha Tau Medical Ltd.
Filing Date: 2025-03-12
Form: 20-F
Item: Item 19
Chunk 320
---
 Foreign                                                642                   916                   679  
  Total                  $                            33,742      $         29,141      $         31,744  

Income tax expense
was as follows:

                          Year ended December 31,                      
                          2022                         2023      2024  
 ───────────────────────────────────────────────────────────────────────
  Current:                                                             
  Domestic (Israel)       $                            $         $     
  Foreign                                                              
  Income tax expense      $                            $         $     

  Net operating losses carry forward:  

The Company has
accumulated losses for tax purposes as of December 31, 2024 in the amount of approximately $71,838which may be carried forward and offset
against taxable income in the future for an indefinite period.

  Deferred taxes:  

Deferred income
taxes reflect the net tax effects of temporary differences between the carrying amounts of assets and liabilities for financial reporting
purposes and the amounts used for income tax purposes. The Company’s deferred tax assets are comprised of operating loss carryforwards
and other temporary differences.

F-29

ALPHA TAU MEDICAL
LTD. AND ITS SUBSIDIARIES

NOTES TO CONSOLIDATED
FINANCIAL STATEMENTS

U. S. dollars
in thousands (except share and per share data)

NOTE 14:- INCOME TAXES (Cont.)

Significant
components of the Company’s deferred tax assets are as follows:

                                                      December 31,                                      
                                                      2023                           2024               
 ────────────────────────────────────────────────────────────────────────────────────────────────────────
  Reserves and allowances                             $                      28      $              35  
  R& D expenses                                                           1,363                  1,537  
  Intangible assets                                                           4                      -  
  Stock-based compensation                                                  140                    254  
  Lease liability                                                         1,041                    954  
  Loss carryforward                                                       4,372                  5,470  
  Deferred tax assets before valuation allowance                          6,948                  8,250  
  Less - valuation allowance                                            ( 5,837                ( 7,135  
  Property and equipment                                                      -                   ( 96  
  ROU Asset                                                             ( 1,111                ( 1,019  
  Deferred tax liabilities                                              ( 1,111                ( 1,115  
  Net deferred taxes                                  $                       -      $               -  

Management currently